{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:08:20Z","timestamp":1773673700527,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000},"content-version":"vor","delay-in-days":791,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.rgmx.2012.10.003","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T12:17:35Z","timestamp":1359721055000},"page":"21-27","source":"Crossref","is-referenced-by-count":7,"title":["Polar vectors as a method for evaluating the effectiveness of irritable bowel syndrome treatments: An analysis with pinaverium bromide 100mg plus simethicone 300mg po bid"],"prefix":"10.1016","volume":"78","author":[{"given":"J.C.","family":"L\u00f3pez-Alvarenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sobrino-Coss\u00edo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Remes-Troche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chiu-Ugalde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Vargas-Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schmulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2012.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","article-title":"The functional gastrointestinal disorders and the Rome III process","volume":"130","author":"Drossman","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0015","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ajg.2010.49","article-title":"Rome Foundation Endpoints and Outcomes Conference 2009: Optimizing Clinical Trials in FGID","volume":"105","author":"Chang","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/ajg.2010.12","article-title":"Evolution of clinical trials for irritable bowel syndrome: issues in end points and study design","volume":"105","author":"Trentacosti","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0025","unstructured":"WMA Declaration of Helsinki \u2013 Ethical Principles for Medical Research Involving Human Subjects [Internet]. World Medical Association; 2008. http:\/\/www.wma.net\/en\/30publications\/10policies\/b3\/index.html [cited on 29.09.10]."},{"key":"10.1016\/j.rgmx.2012.10.003_bib0030","unstructured":"International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice E6 (R1); 10 June 1996. Available from: http:\/\/www.ich.org\/fileadmin\/Public_Web_Site\/ICH_Products\/Guidelines\/Efficacy\/E6_R1\/Step4\/E6_R1__Guideline.pdf."},{"key":"10.1016\/j.rgmx.2012.10.003_bib0035","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1053\/j.gastro.2008.09.005","article-title":"Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles","volume":"135","author":"Camilleri","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.gtc.2011.01.001","article-title":"Potential biomarkers","volume":"40","author":"Spiller","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0065","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1136\/gut.2008.169672","article-title":"Biomarkers in IBS: when will they replace symptoms for diagnosis and management?","volume":"58","author":"Barbara","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0045","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2009.04144.x","article-title":"Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale","volume":"30","author":"Spiegel","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0050","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1572-0241.2006.00592.x","article-title":"Functional versus organic: an inappropriate dichotomy for clinical care","volume":"101","author":"Drossman","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmx.2012.10.003_bib0055","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1365-2036.2010.04464.x","article-title":"Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials","volume":"32","author":"Spiegel","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.rgmx.2012.10.003_bib0060","first-page":"11","article-title":"Abdominal pain and anxiety are linked factors that affect the quality of life of patients with IBS","volume":"29","author":"Schmulson","year":"2011","journal-title":"Neurogastroenterol Motil"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090612001358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090612001358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T01:55:41Z","timestamp":1539914141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090612001358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0375090612001358"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2012.10.003","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}